The Board of Directors approved a share repurchase authorization for up to $3.3 billion effective from August 1, 2024 to December 31, 2026. This indicates management's confidence in the company's financial position and future prospects.

The Company filed an automatic shelf registration statement with the SEC for the potential offering and sale of debt and equity securities. This provides flexibility for future capital raising activities.

The Hartford Next plan reduced annual insurance operating costs and other expenses through headcount reduction and investment in IT. The activities were substantially completed as of December 31, 2023, indicating successful execution of the plan.

The Company is still facing lawsuits seeking insurance coverage under commercial insurance policies for alleged losses resulting from the shutdown or suspension of their businesses due to the spread of COVID-19. The outcome in certain matters could have a material adverse effect on the Company's results of operations or cash flows in particular quarterly or annual periods.

The Company continues to receive A&E claims and significant uncertainty limits the ability of insurers and reinsurers to estimate the ultimate reserves necessary for unpaid losses and related expenses. The ultimate liabilities, thus, could exceed the currently recorded reserves, and any such additional liability, while not estimable now, could be material to The Hartford's consolidated operating results or liquidity.

Most of Personal Lines written premium is associated with our exclusive licensing agreement with AARP, which is effective through December 31, 2032. This agreement provides an important competitive advantage given the size of the 50 plus population and the strength of the AARP brand.

During the nine months ended September 30, 2024, the Company repurchased $1.1 billion of common stock under the $3.0 billion share repurchase authorization. This indicates a commitment to returning capital to shareholders.

The Company is exposed to risks relating to economic, political and global market conditions, and the effect of financial market disruptions, economic downturns, changes in trade regulation including tariffs and other barriers or other potentially adverse macroeconomic developments on the demand for our products and returns in our investment portfolios.